Back to Neurology

OUR EXPERTISE AND AND SERVICES AVAILABLE IN

Migraine

Overview

Spherix’s coverage of the migraine market tracks the impact of expanding therapeutic choice on migraine management. Broad coverage of both the acute and preventive segments allows Spherix to assess the interplay of market dynamics for the treatment of episodic and chronic migraine.

Services Available

Trending market evolution

  • Migraine – Specialist Perspective (US) - quarterly, n=100

  • Migraine – PCP Perspective (US) - semiannual, n=100

Exploring the patient journey

  • Acute Treatment Switching in Migraine (US) - n=1,000 patient charts

  • Preventive Treatment Switching in Migraine (US) - n=1,000 patient charts

Benchmarking New Brand Performance

  • Atogepant (Allergan/AbbVie) in Migraine Prevention (US)*

  • Nurtec ODT (Biohaven) for Prevention in Migraine (US)*

*Pending approvals and launch

Gauging impact of disruptive events

  • Multi-Specialty Impact of COVID-19 (US)

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Migraine Coverage